• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从耳真菌病患者中分离出的酵母和霉菌的分子鉴定及抗真菌药敏试验。

Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.

机构信息

Department of Ear, Nose, and Throat, Faculty of Medicine, Roohani Hospital, Babol University of Medical Sciences, Babol, Iran.

Department of Medical Mycology, School of Medicine, Babol University of Medical Sciences, 47745-47176, Babol, Iran.

出版信息

Mycopathologia. 2021 May;186(2):245-257. doi: 10.1007/s11046-021-00537-1. Epub 2021 Mar 15.

DOI:10.1007/s11046-021-00537-1
PMID:33718990
Abstract

Fungal otitis externa, an infection of the external auditory canal caused by molds and yeasts, accounts for approximately 10-20% of ear canal infections accompanying high recurrence. The purpose of the current study was to assess the pattern of etiological agents of otomycosis and resistance profile as well as the rate of tympanic membrane perforation. A total of 1040 patients with symptoms of fungal otitis externa, in a period of two years, were investigated. The mycological tests revealed the presence of different fungi in 237 ears (22.8%). Fungal otitis was more related to filamentous fungi of the species Aspergillus flavus (54.43%), A. tubingensis (10.97%), and A. niger (8.86%), followed by yeasts, Candida orthopsilosis (7.59%), C. albicans (6.75%), and C. parapsilosis (5.06%). Tympanic membrane perforation rate was found to be 6.75% and was more common with otomycosis caused by A. flavus, A. tubingensis and C. albicans. In antifungal susceptibility tests, all tested drugs showed generally good activity against most isolates of molds and yeasts, while tolnaftate, clotrimazole, nystatin, and terbinafine had lowest effects. We found that among Aspergillus isolates, one A. niger isolate was resistant to voriconazole, and one A. flavus isolate was resistant to amphotericin B. Furthermore, among Candida species, three isolates of C. orthopsilosis showed high MIC values to fluconazole, two C. albicans isolates were considered fluconazole resistant and one isolate of C. parapsilosis was resistant to caspofungin and 3 isolates were resistant to fluconazole. Regarding the existence of the cases with perforated tympanic membrane and emerging species causing fungal otitis in the current report, the importance of the early physical examination, precise molecular identification, and the antifungal susceptibility evaluation is highlighted.

摘要

真菌性外耳道炎是一种由霉菌和酵母菌引起的外耳道感染,约占伴有高复发率的耳道感染的 10-20%。本研究的目的是评估耳霉菌病的病原体模式和耐药谱以及鼓膜穿孔率。在两年的时间里,对 1040 名有真菌性外耳道炎症状的患者进行了调查。 1040 名患者中,237 名患者(22.8%)的真菌学检查显示存在不同的真菌。真菌性外耳道炎与黄曲霉(54.43%)、烟曲霉(10.97%)和黑曲霉(8.86%)等丝状真菌关系更为密切,其次是念珠菌属,近平滑念珠菌(7.59%)、白念珠菌(6.75%)和葡萄牙念珠菌(5.06%)。发现鼓膜穿孔率为 6.75%,且由黄曲霉、烟曲霉和白念珠菌引起的耳霉菌病更为常见。在抗真菌药敏试验中,所有测试药物对大多数霉菌和酵母菌分离株均表现出良好的活性,而托萘酯、克霉唑、制霉菌素和特比萘芬的效果最差。我们发现,在黑曲霉分离株中,1 株黑曲霉对伏立康唑耐药,1 株黄曲霉对两性霉素 B 耐药。此外,在念珠菌属中,3 株近平滑念珠菌对氟康唑的 MIC 值较高,2 株白念珠菌被认为对氟康唑耐药,1 株葡萄牙念珠菌对卡泊芬净耐药,3 株对氟康唑耐药。关于当前报告中存在鼓膜穿孔和新出现的引起真菌性外耳道炎的病例,强调了早期体格检查、准确的分子鉴定和抗真菌药敏评估的重要性。

相似文献

1
Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.从耳真菌病患者中分离出的酵母和霉菌的分子鉴定及抗真菌药敏试验。
Mycopathologia. 2021 May;186(2):245-257. doi: 10.1007/s11046-021-00537-1. Epub 2021 Mar 15.
2
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
3
Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.韦氏曲霉;一种主要引起耳真菌病的病原体,来自伊朗的新流行病学和抗真菌药敏数据。
Microb Pathog. 2023 Aug;181:106180. doi: 10.1016/j.micpath.2023.106180. Epub 2023 May 29.
4
Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.从耳真菌病患者中分离的曲霉属 Nigri 节段菌株的种属鉴定和体外抗真菌药敏试验。
J Mycol Med. 2018 Jun;28(2):279-284. doi: 10.1016/j.mycmed.2018.02.003. Epub 2018 Mar 11.
5
Otomycosis: The foremost aetiological agent causing otitis externa and the antifungal susceptibility pattern in North-Western Iran.外耳道真菌病:伊朗西北部引起外耳道炎的主要病原体及抗真菌药敏模式
Mycoses. 2023 Feb;66(2):87-97. doi: 10.1111/myc.13532. Epub 2022 Sep 26.
6
The Role of Candida Albicans in Routine Clinically Suspected Otomycosis.白色念珠菌在临床疑似耳真菌病中的作用。
West Afr J Med. 2021 Aug 30;38(8):743-748.
7
Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.从中国西部耳真菌病患者中分离出的曲霉菌的分子鉴定及体外抗真菌药敏试验。
Mycopathologia. 2020 Jun;185(3):527-535. doi: 10.1007/s11046-020-00448-7. Epub 2020 Apr 28.
8
Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.从巴西东南部医院分离出的近平滑念珠菌(广义):菌种分布、抗真菌药敏性及毒力特性
Int J Med Microbiol. 2015 Dec;305(8):848-59. doi: 10.1016/j.ijmm.2015.08.003. Epub 2015 Aug 14.
9
A retrospective study of 43 cases of fungal malignant external otitis.回顾性研究 43 例真菌性恶性外耳炎。
Pan Afr Med J. 2022 Apr 8;41:287. doi: 10.11604/pamj.2022.41.287.29585. eCollection 2022.
10
Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary.匈牙利耳真菌病病例中黑色曲霉菌的分子鉴定及抗真菌药敏性
Mycopathologia. 2012 Aug;174(2):143-7. doi: 10.1007/s11046-012-9529-8. Epub 2012 Feb 23.

引用本文的文献

1
Otomycosis: a systematic review and meta-analysis of prevalence and causative agents in the era of molecular diagnostics.耳霉菌病:分子诊断时代患病率及病原体的系统评价与荟萃分析
BMC Infect Dis. 2025 Apr 17;25(1):544. doi: 10.1186/s12879-025-10954-y.
2
[Analysis of fungal infections of external auditory canal and its risk factors in patients with chronic otitis media].[慢性中耳炎患者外耳道真菌感染及其危险因素分析]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 Jan;39(1):57-60. doi: 10.13201/j.issn.2096-7993.2025.01.012.
3
Pathogenic Aspergillus Strains Identification and Antifungal Susceptibility Analysis of 452 Cases with Otomycosis in Jingzhou, China.

本文引用的文献

1
Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.伊朗阿瓦士耳霉菌病病原体的抗真菌药敏谱
Curr Med Mycol. 2020 Jun;6(2):18-22. doi: 10.18502/CMM.6.2.2696.
2
Eradicating Otomycosis with Terbinafine Solution: Basic and Clinical Investigation.用特比萘芬溶液根除耳真菌病:基础与临床研究
Audiol Neurootol. 2019;24(4):183-190. doi: 10.1159/000501540. Epub 2019 Aug 27.
3
Diagnosis and treatment of otomycosis in southern China.中国南方的耳真菌病的诊断与治疗。
中国荆州 452 例耳真菌病患者的致病曲霉菌株鉴定及抗真菌药敏分析。
Mycopathologia. 2024 Apr 5;189(2):30. doi: 10.1007/s11046-024-00836-3.
4
Study on the microbial diversity of ear canal secretions from patients with otomycosis.外耳道真菌病患者耳道分泌物微生物多样性研究
Front Surg. 2024 Feb 9;11:1277799. doi: 10.3389/fsurg.2024.1277799. eCollection 2024.
5
Identification of Microbial Community in Otomycosis by Metagenomic Next Generation Sequencing (mNGS): Potential Implication of Treatment with Terbinafine.基于宏基因组下一代测序(mNGS)对真菌性外耳道炎微生物群落的鉴定:特比萘芬治疗的潜在意义。
Mycopathologia. 2023 Dec;188(6):995-1005. doi: 10.1007/s11046-023-00791-5. Epub 2023 Sep 19.
6
Antifungal Resistance of Clinical Isolates in Iran: A Systematic Review and Meta-Analysis.伊朗临床分离株的抗真菌耐药性:一项系统评价和荟萃分析。
Iran J Public Health. 2023 Feb;52(2):290-305. doi: 10.18502/ijph.v52i2.11874.
7
In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis.体外联合特比萘芬与酮康唑治疗体外分离的高特比萘芬 MIC 值烟曲霉菌属致外耳道真菌病。
Mycopathologia. 2023 Apr;188(1-2):119-127. doi: 10.1007/s11046-022-00698-7. Epub 2022 Nov 30.
8
A Whole Genome Sequencing-Based Approach to Track down Genomic Variants in Itraconazole-Resistant Species of from Iran.一种基于全基因组测序的方法来追踪伊朗伊曲康唑耐药菌种中的基因组变异。
J Fungi (Basel). 2022 Oct 17;8(10):1091. doi: 10.3390/jof8101091.
9
Identification of the Fungal Community in Otomycosis by Internal Transcribed Spacer Sequencing.通过内转录间隔区测序鉴定耳真菌病中的真菌群落
Front Microbiol. 2022 Mar 15;13:820423. doi: 10.3389/fmicb.2022.820423. eCollection 2022.
10
Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study.伊朗南部地区耳真菌病高发伴鼓膜穿孔:一项基于医院的研究。
Mycopathologia. 2022 Jun;187(2-3):225-233. doi: 10.1007/s11046-022-00626-9. Epub 2022 Mar 26.
Mycoses. 2019 Nov;62(11):1064-1068. doi: 10.1111/myc.12979. Epub 2019 Sep 2.
4
Potential Fifth Clade of Candida auris, Iran, 2018.2018 年,伊朗发现了潜在的第五组假丝酵母菌属(Candida auris)。
Emerg Infect Dis. 2019 Sep;25(9):1780-1781. doi: 10.3201/eid2509.190686. Epub 2019 Sep 17.
5
Otomycosis With Tympanic Membrane Perforation: A Review of the Literature.鼓膜穿孔性真菌性外耳炎:文献复习。
Ear Nose Throat J. 2020 Sep;99(8):518-521. doi: 10.1177/0145561319851499. Epub 2019 May 29.
6
Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents.伊什法罕耳真菌病的分子流行病学显示,病原体具有很大的多样性。
J Med Microbiol. 2019 Jun;68(6):918-923. doi: 10.1099/jmm.0.000985. Epub 2019 May 7.
7
Bayesian analysis of two methods MALDI-TOF-MS system and culture test in otomycosis infection.两种方法(基质辅助激光解吸电离飞行时间质谱系统和培养试验)在耳真菌病感染中的贝叶斯分析。
World J Otorhinolaryngol Head Neck Surg. 2019 Jan 4;5(1):6-13. doi: 10.1016/j.wjorl.2018.03.006. eCollection 2019 Mar.
8
A search for new otomycotic species and their sensitivity to different antifungals.寻找新的耳霉菌种及其对不同抗真菌药物的敏感性。
Interv Med Appl Sci. 2018 Sep;10(3):145-149. doi: 10.1556/1646.10.2018.28.
9
Candida auris otomycosis in Iran and review of recent literature.伊朗的耳念珠菌真菌病及近期文献回顾。
Mycoses. 2019 Feb;62(2):101-105. doi: 10.1111/myc.12886.
10
Single Dose Topical Application of Clotrimazole for the Treatment of Otomycosis: Is This Enough?克霉唑单剂量局部应用治疗耳真菌病:这足够吗?
J Audiol Otol. 2019 Jan;23(1):15-19. doi: 10.7874/jao.2018.00276. Epub 2018 Dec 7.